Richard Glennon

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Radioligand Assay

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Keiser Michael J; Setola Vincent; Irwin John J; Laggner Christian; Abbas Atheir I; Hufeisen Sandra J; Jensen Niels H; Kuijer Michael B; Matos Roberto C; Tran Thuy B; Whaley Ryan; Glennon Richard A; Hert Jérôme; Thomas Kelan L H; Edwards Douglas D; Shoichet Brian K; Roth Bryan L
Predicting new molecular targets for known drugs.
Young Richard; Glennon Richard A
S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats.
Runyon Scott P; Mosier Philip D; Roth Bryan L; Glennon Richard A; Westkaemper Richard B
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Glennon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Keiser Michael J; Setola Vincent; Irwin John J; Laggner Christian; Abbas Atheir I; Hufeisen Sandra J; Jensen Niels H; Kuijer Michael B; Matos Roberto C; Tran Thuy B; Whaley Ryan; Glennon Richard A; Hert Jérôme; Thomas Kelan L H; Edwards Douglas D; Shoichet Brian K; Roth Bryan L
Predicting new molecular targets for known drugs.
Nature 2009;462(7270):175-81.
2009: Young Richard; Glennon Richard A
S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats.
Psychopharmacology 2009;203(2):369-82.
2008: Runyon Scott P; Mosier Philip D; Roth Bryan L; Glennon Richard A; Westkaemper Richard B
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Journal of medicinal chemistry 2008;51(21):6808-28.
2008: Dukat Malgorzata; Mosier Philip D; Kolanos Renata; Roth Bryan L; Glennon Richard A
Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.
Journal of medicinal chemistry 2008;51(3):603-11.
2008: Young Richard; Glennon Richard A
MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice.
Pharmacology, biochemistry, and behavior 2008;88(3):318-31.
2007: Kim Jin-Sung; Padnya Anshul; Weltzin Maegan; Edmonds Brian W; Schulte Marvin K; Glennon Richard A
Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.
Bioorganic & medicinal chemistry letters 2007;17(17):4855-60.
2007: Dukat Malgorzata; Wesolowska Anna; Young Richard; Glennon Richard A
The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
Pharmacology, biochemistry, and behavior 2007;87(2):203-7.
2007: Glennon Richard A; Young Richard; Dukat Malgorzata; Chang-Fong Jean; El-Zahabi Mohamed
N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats.
Pharmacology, biochemistry, and behavior 2007;86(3):477-84.
2007: Nyandege Abner; Kolanos Renata; Roth Bryan L; Glennon Richard A
Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2007;17(6):1691-4.
2007: Dukat Malgorzata; Glennon Richard A; Young Shawquia
MD-354: what is it good for?
CNS drug reviews 2007;13(1):1-20.
2006: Kolanos Renata; Dukat Malgorzata; Roth Bryan L; Glennon Richard A
Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2006;16(22):5832-5.
2006: Glennon Richard A; Bondareva Tatiana; Young Richard
alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.
Pharmacology, biochemistry, and behavior 2006;85(2):448-53.
2006: Young Richard; Bondareva Tatiana; Wesolowska Anna; Young Shawquia; Glennon Richard A
Effect of the 5-HT(6) serotonin antagonist MS-245 on the actions of (-)nicotine.
Pharmacology, biochemistry, and behavior 2006;85(1):170-7.
2006: Sikazwe Donald; Bondarev Mikhail L; Dukat Malgorzata; Rangisetty Jagadeesh B; Roth Bryan L; Glennon Richard A
Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors.
Journal of medicinal chemistry 2006;49(17):5217-25.
2006: Ragab Hanan M; Kim Jin Sung; Dukat Malgorzata; Navarro Hernán; Glennon Richard A
Aryloxyethylamines: binding at alpha7 nicotinic acetylcholine receptors.
Bioorganic & medicinal chemistry letters 2006;16(16):4283-6.
2006: Siripurapu Uma; Kolanos Renata; Dukat Malgorzata; Roth Bryan L; Glennon Richard A
Binding of methoxy-substituted N1-benzenesulfonylindole analogs at human 5-HT6 serotonin receptors.
Bioorganic & medicinal chemistry letters 2006;16(14):3793-6.
2006: Young Richard; Batkai Sandor; Dukat Malgorzata; Glennon Richard A
TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice.
Pharmacology, biochemistry, and behavior 2006;84(1):62-73.
2006: Young Richard; Rothman Richard B; Rangisetty Jagadeesh B; Partilla John S; Dukat Malgorzata; Glennon Richard A
TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) inhibits the consumption of "snacks" in mice.
Pharmacology, biochemistry, and behavior 2006;84(1):74-83.
2006: Young Richard; Bondareva Tatiana; Wesolowska Anna; Glennon Richard A
Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT).
Pharmacology, biochemistry, and behavior 2006;83(4):612-7.
2005: Pullagurla Manik; Siripurapu Uma; Kolanos Renata; Bondarev Mikhail L; Dukat Malgorzata; Setola V; Roth B L; Glennon Richard A
Binding of amine-substituted N1-benzenesulfonylindoles at human 5-HT6 serotonin receptors.
Bioorganic & medicinal chemistry letters 2005;15(23):5298-302.
2005: Bondareva Tatiana; Wesolowska Anna; Dukat Malgorzata; Lee Mase; Young Richard; Glennon Richard A
S(+)- and R(-)N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: effect of cocaine.
Pharmacology, biochemistry, and behavior 2005;82(3):531-8.
2005: Young Richard; Khorana Nantaka; Bondareva Tatiana; Glennon Richard A
Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA).
Pharmacology, biochemistry, and behavior 2005;82(2):404-10.
2005: Glennon R A
Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach.
Mini reviews in medicinal chemistry 2005;5(10):927-40.
2005: Dukat Malgorzata; Ramunno Anna; Banzi Rita; Damaj M Imad; Martin Billy; Glennon Richard A
3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.
Bioorganic & medicinal chemistry letters 2005;15(19):4308-12.
2005: Abate Carmen; Kolanos Renata; Dukat Malgorzata; Setola Vince; Roth Bryan L; Glennon Richard A
Interaction of chiral MS-245 analogs at h5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2005;15(15):3510-3.
2005: Ramunno Anna; Dukat Malgorzata; Lee Mase; Young Richard; El-Zahabi Mohamed; Damaj M Imad; Martin Billy; Glennon Richard A
6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand.
Bioorganic & medicinal chemistry letters 2005;15(13):3237-40.
2005: Setola Vincent; Dukat Malgorzata; Glennon Richard A; Roth Bryan L
Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.
Molecular pharmacology 2005;68(1):20-33.
2005: Kolanos Renata; Siripurapu Uma; Pullagurla Manik; Riaz Mohamed; Setola Vince; Roth Bryan L; Dukat Malgorzata; Glennon Richard A
Binding of isotryptamines and indenes at h5-HT6 serotonin receptors.
Bioorganic & medicinal chemistry letters 2005;15(8):1987-91.
2005: Lee Mase; Rangisetty Jagadeesh B; Pullagurla Manik R; Dukat Malgorzata; Setola Vince; Roth Bryan L; Glennon Richard A
1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands.
Bioorganic & medicinal chemistry letters 2005;15(6):1707-11.
2004: Glennon Richard A; Bondarev Mikhail L; Khorana Nantaka; Young Richard; May Jesse A; Hellberg Mark R; McLaughlin Marsha A; Sharif Najam A
Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
Journal of medicinal chemistry 2004;47(24):6034-41.
2004: Pullagurla Manik R; Westkaemper Richard B; Glennon Richard A
Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2004;14(17):4569-73.
2004: Prisinzano Thomas; Dukat Malgorzata; Law Ho; Slassi Abdelmalik; MacLean Neil; DeLannoy Inés; Glennon Richard A
2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(18):4697-9.
2004: Khorana Nantaka; Pullagurla Manik R; Dukat Malgorzata; Young Richard; Glennon Richard A
Stimulus effects of three sulfur-containing psychoactive agents.
Pharmacology, biochemistry, and behavior 2004;78(4):821-6.
2004: Dukat Malgorzata; Taroua Mohamed; Dahdouh Abdelaziz; Siripurapu Umamaheswar; Damaj M Imad; Martin Billy R; Glennon Richard A
(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents.
Bioorganic & medicinal chemistry letters 2004;14(14):3651-4.
2004: Pullagurla Manik; Bondareva Tatiana; Young Richard; Glennon Richard A
Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245.
Pharmacology, biochemistry, and behavior 2004;78(2):263-8.
2004: Khorana Nantaka; Pullagurla Manik R; Young Richard; Glennon Richard A
Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization.
Drug and alcohol dependence 2004;74(3):281-7.
2004: Dukat Malgorzata; Smith Carol; Herrick-Davis Katharine; Teitler Milt; Glennon Richard A
Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry 2004;12(10):2545-52.
2004: Peddi Srinivas; Roth Bryan L; Glennon Richard A; Westkaemper Richard B
Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).
Bioorganic & medicinal chemistry letters 2004;14(9):2279-83.
2004: Glennon Richard A; Ismaiel Abd M; Ablordeppey Seth; El-Ashmawy Mahmoud; Fisher James B
Thioxanthene-derived analogs as sigma(1) receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(9):2217-20.
2004: Chang-Fong Jean; Rangisetty Jagadeesh B; Dukat Malgorzata; Setola Vincent; Raffay Thomas; Roth Bryan; Glennon Richard A
1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(8):1961-4.
2004: Glennon Richard A; Dukat Malgorzata
alpha4beta2 nACh receptor pharmacophore models.
Bioorganic & medicinal chemistry letters 2004;14(8):1841-4.
2004: Chang-Fong Jean; Tyacke Robin J; Lau Alice; Westaway Julie; Hudson Alan L; Glennon Richard A
Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(4):1003-5.
2004: Glennon Richard A; Grella Brian; Tyacke Robin J; Lau Alice; Westaway Julie; Hudson Alan L
Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry letters 2004;14(4):999-1002.
2004: Glennon Richard A; Grella Brian; Tyacke Robin J; Lau Alice; Westaway Julie; Hudson Alan L
Binding of an imidazopyridoindole at imidazoline I2 receptors.
Bioorganic & medicinal chemistry letters 2004;14(2):527-9.
2004: Dogruer Deniz; Lee Mase; Dukat Malgorzata; Damaj M Imad; Martin Billy R; Glennon Richard A
3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors.
Bioorganic & medicinal chemistry letters 2004;14(2):523-6.
2004: Glennon Richard A
2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands.
Progress in medicinal chemistry 2004;42():55-123.
2004: Glennon Richard A; Dukat Malgorzata; Liao Liang
Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models.
Current topics in medicinal chemistry 2004;4(6):631-44.
2003: Tyacke R J; Lau A; Grella B; Glennon R A; Nutt D J; Hudson A L
Investigation of the affinities of two new beta-carbolines for rat brain imidazoline(2) receptors.
Annals of the New York Academy of Sciences 2003;1009():361-3.
2003: Peddi Srinivas; Roth Bryan L; Glennon Richard A; Westkaemper Richard B
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.
European journal of pharmacology 2003;482(1-3):335-7.
2003: Grella Brian; Teitler Milt; Smith Carol; Herrick-Davis Katharine; Glennon R A
Binding of beta-carbolines at 5-HT(2) serotonin receptors.
Bioorganic & medicinal chemistry letters 2003;13(24):4421-5.
2003: Glennon Richard A; Daoud Maha Khalifa; Dukat Malgorzata; Teitler Milt; Herrick-Davis Katharine; Purohit Anil; Syed Hasan
Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: a QSAR study.
Bioorganic & medicinal chemistry 2003;11(20):4449-54.
2003: Rothman Richard B; Vu Nga; Partilla John S; Roth Bryan L; Hufeisen Sandra J; Compton-Toth Beth A; Birkes Jon; Young Richard; Glennon Richard A
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates.
The Journal of pharmacology and experimental therapeutics 2003;307(1):138-45.
2003: Pullagurla Manik R; Dukat Malgorzata; Setola Vincent; Roth Bryan; Glennon Richard A
N1-benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates.
Bioorganic & medicinal chemistry letters 2003;13(19):3355-9.
2003: Simsek Rahime; Chang-Fong Jean; Lee Mase; Dukat Malgorzata; Imad Damaj M; Martin Billy R; Glennon Richard A
Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents.
Bioorganic & medicinal chemistry letters 2003;13(17):2917-20.
2003: Khorana Nantaka; Smith Carol; Herrick-Davis Kathy; Purohit Anil; Teitler Milt; Grella Brian; Dukat Malgorzata; Glennon Richard A
Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
Journal of medicinal chemistry 2003;46(18):3930-7.
2003: Bondarev Mikhail L; Bondareva Tatiana S; Young Richard; Glennon Richard A
Behavioral and biochemical investigations of bupropion metabolites.
European journal of pharmacology 2003;474(1):85-93.
2003: Peddi Srinivas; Roth Bryan L; Glennon Richard A; Westkaemper Richard B
Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor.
Bioorganic & medicinal chemistry letters 2003;13(15):2565-8.
2003: Eckler J R; Chang-Fong J; Rabin R A; Smith C; Teitler M; Glennon R A; Winter J C
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
Pharmacology, biochemistry, and behavior 2003;75(4):845-52.
2003: Glennon Richard A
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Journal of medicinal chemistry 2003;46(14):2795-812.
2003: Dukat Malgorzata; Glennon Richard A
Epibatidine: impact on nicotinic receptor research.
Cellular and molecular neurobiology 2003;23(3):365-78.
2003: Setola Vincent; Hufeisen Sandra J; Grande-Allen K Jane; Vesely Ivan; Glennon Richard A; Blough Bruce; Rothman Richard B; Roth Bryan L
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
Molecular pharmacology 2003;63(6):1223-9.
2003: Rahman Ashraf A; Daoud Maha Khalifa; Dukat Malgorzata; Herrick-Davis Katharine; Purohit Anil; Teitler Milt; do Amaral Antonia Taveres; Malvezzi Alberto; Glennon Richard A
Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG).
Bioorganic & medicinal chemistry letters 2003;13(6):1119-23.
2003: Khorana Nantaka; Purohit Anil; Herrick-Davis Katherine; Teitler Milt; Glennon Richard A
gamma-Carbolines: binding at 5-HT5A serotonin receptors.
Bioorganic & medicinal chemistry 2003;11(5):717-22.
2003: Ferretti G; Dukat M; Giannella M; Piergentili A; Pigini M; Quaglia W; Damaj M I; Martin B R; Glennon R A
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors.
Bioorganic & medicinal chemistry letters 2003;13(4):733-5.
2002: Bondareva Tatiana S; Young Richard; Glennon Richard A
Central stimulants as discriminative stimuli. Asymmetric generalization between (-)ephedrine and S(+)methamphetamine.
Pharmacology, biochemistry, and behavior 2002;74(1):157-62.
2002: Ferretti G; Dukat M; Giannella M; Piergentili A; Pigini M; Quaglia W; Damaj M I; Martin B R; Glennon R A
Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.
Journal of medicinal chemistry 2002;45(21):4724-31.
2002: Dukat Malgorzata; El-Zahabi Mohamed; Ferretti Giovanni; Damaj M Imad; Martin Billy R; Young Richard; Glennon Richard A
(-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine.
Bioorganic & medicinal chemistry letters 2002;12(20):3005-7.
2002: Lee Mase; Dukat Malgorzata; Liao Liang; Flammia Dwight; Damaj M Imad; Martin Billy; Glennon Richard A
A comparison of the binding of three series of nicotinic ligands.
Bioorganic & medicinal chemistry letters 2002;12(15):1989-92.
2002: Westkaemper Richard B; Glennon Richard A
Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
Current topics in medicinal chemistry 2002;2(6):575-98.
2002: Glennon Richard A; Metwally Kamel; Dukat Malgorzata; Ismaiel Abd M; De los Angeles Joseph; Herndon Jeffery; Teitler Milt; Khorana Nantaka
Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
Current topics in medicinal chemistry 2002;2(6):539-58.
2002: Young Richard; Glennon Richard A
Nicotine and bupropion share a similar discriminative stimulus effect.
European journal of pharmacology 2002;443(1-3):113-8.
2002: Glennon Richard A; Young Richard; Rangisetty Jagadeesh B
Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline.
Pharmacology, biochemistry, and behavior 2002;72(1-2):379-87.
2002: Glennon Richard A; Young Richard
Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats.
Pharmacology, biochemistry, and behavior 2002;72(1-2):307-11.
2002: Dukat Malgorzata; Young Richard; Glennon Richard A
Effect of PMA optical isomers and 4-MTA in PMMA-trained rats.
Pharmacology, biochemistry, and behavior 2002;72(1-2):299-305.
2002: Runyon Scott P; Peddi Srinivas; Savage Jason E; Roth Bryan L; Glennon Richard A; Westkaemper Richard B
Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Journal of medicinal chemistry 2002;45(8):1656-64.
2002: Dukat Malgorzata; Damaj Imad M; Young Richard; Vann Robert; Collins Allan C; Marks Michael J; Martin Billy R; Glennon Richard A
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations.
European journal of pharmacology 2002;435(2-3):171-80.
2002: Young Richard; Glennon Richard A
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine.
Pharmacology, biochemistry, and behavior 2002;71(1-2):205-13.
2002: Chang-Fong Jean; Addo James; Dukat Malgorzata; Smith Carol; Mitchell Nicholas A; Herrick-Davis Katharine; Teitler Milt; Glennon Richard A
Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors.
Bioorganic & medicinal chemistry letters 2002;12(2):155-8.
2001: Hong S S; Young R; Glennon R A
Discriminative stimulus properties of alpha-ethyltryptamine optical isomers.
Pharmacology, biochemistry, and behavior 2001;70(2-3):311-6.
2001: Rangisetty J B; Dukat M; Dowd C S; Herrick-Davis K; DuPre A; Gadepalli S; Teitler M; Kelley C R; Sharif N A; Glennon R A
1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character.
Journal of medicinal chemistry 2001;44(20):3283-91.
2001: Dukat M; Choi Y N; Teitler M; Du Pre A; Herrick-Davis K; Smith C; Glennon R A
The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry letters 2001;11(12):1599-603.
2001: Rangisetty J B; Bondarev M L; Chang-Fong J; Young R; Glennon R A
PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
Pharmacology, biochemistry, and behavior 2001;69(1-2):261-7.
2001: Prisinzano T; Law H; Dukat M; Slassi A; MaClean N; Demchyshyn L; Glennon R A
Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands.
Bioorganic & medicinal chemistry 2001;9(3):613-9.
2001: Runyon S P; Savage J E; Taroua M; Roth B L; Glennon R A; Westkaemper R B
Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Bioorganic & medicinal chemistry letters 2001;11(5):655-8.
2001: Westkaemper R B; Runyon S P; Savage J E; Roth B L; Glennon R A
Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor.
Bioorganic & medicinal chemistry letters 2001;11(4):563-6.
2000: Ferretti G; Dukat M; Giannella M; Piergentili A; Pigini M; Quaglia W; Damaj M I; Martin B R; Glennon R A
Chain-lengthened and imidazoline analogues of nicotine.
Bioorganic & medicinal chemistry letters 2000;10(23):2665-8.
2000: Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage J E; Roth B L; Hufesein S; Lee M; Glennon R A
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
Bioorganic & medicinal chemistry letters 2000;10(20):2295-9.
2000: Hellberg M; Stubbins J F; Glennon R A
A preliminary investigation of mesoionic xanthine analogues as inhibitors of platelet aggregation.
Bioorganic & medicinal chemistry 2000;8(8):1917-23.
2000: Dowd C S; Herrick-Davis K; Egan C; DuPre A; Smith C; Teitler M; Glennon R A
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
Journal of medicinal chemistry 2000;43(16):3074-84.
2000: Glennon R A; Dukat M; Grella B; Hong S; Costantino L; Teitler M; Smith C; Egan C; Davis K; Mattson M V
Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors.
Drug and alcohol dependence 2000;60(2):121-32.
2000: Young R; Glennon R A
Stimulus effects of phenylpropanolamine optical isomers in (+)amphetamine-trained rats.
Pharmacology, biochemistry, and behavior 2000;66(3):489-94.
2000: Glennon R A; Young R
MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin.
Pharmacology, biochemistry, and behavior 2000;66(3):483-8.
2000: Dukat M; Young R; Darmani N N; Ahmed B; Glennon R A
The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay.
Psychopharmacology 2000;150(2):200-7.
2000: Kristiansen K; Kroeze W K; Willins D L; Gelber E I; Savage J E; Glennon R A; Roth B L
A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
The Journal of pharmacology and experimental therapeutics 2000;293(3):735-46.
2000: Glennon R A; Young R
(+)Amphetamine-stimulus generalization to an herbal ephedrine product.
Pharmacology, biochemistry, and behavior 2000;65(4):655-8.
2000: Glennon R A; Dukat M
Central nicotinic receptor ligands and pharmacophores.
Pharmaceutica acta Helvetiae 2000;74(2-3):103-14.
2000: Glennon R A; Lee M; Rangisetty J B; Dukat M; Roth B L; Savage J E; McBride A; Rauser L; Hufeisen S; Lee D K
2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.
Journal of medicinal chemistry 2000;43(5):1011-8.
1999: Young R; Bondarev M; Glennon R A
An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats.
Drug and alcohol dependence 1999;57(1):1-6.
1999: Young R; Dukat M; Malmusi L; Glennon R A
Stimulus properties of PMMA: effect of optical isomers and conformational restriction.
Pharmacology, biochemistry, and behavior 1999;64(2):449-53.
1999: Glennon R A
Arylalkylamine drugs of abuse: an overview of drug discrimination studies.
Pharmacology, biochemistry, and behavior 1999;64(2):251-6.
1999: Westkaemper R B; Runyon S P; Bondarev M L; Savage J E; Roth B L; Glennon R A
9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
European journal of pharmacology 1999;380(1):R5-7.
1999: Flammia D; Dukat M; Damaj M I; Martin B; Glennon R A
Lobeline: structure-affinity investigation of nicotinic acetylcholinergic receptor binding.
Journal of medicinal chemistry 1999;42(18):3726-31.
1998: Young R; Glennon R A
Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse.
Psychopharmacology 1998;140(3):250-6.
1998: Metwally K A; Dukat M; Egan C T; Smith C; DuPre A; Gauthier C B; Herrick-Davis K; Teitler M; Glennon R A
Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Journal of medicinal chemistry 1998;41(25):5084-93.
1998: Young R; Gabryszuk M; Glennon R A
(-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects.
Pharmacology, biochemistry, and behavior 1998;61(2):169-73.
1998: Young R; Glennon R A
Discriminative stimulus properties of (-)ephedrine.
Pharmacology, biochemistry, and behavior 1998;60(3):771-5.
1998: Law H; Dukat M; Teitler M; Lee D K; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon R A
Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
Journal of medicinal chemistry 1998;41(13):2243-51.
1998: Grella B; Dukat M; Young R; Teitler M; Herrick-Davis K; Gauthier C B; Glennon R A
Investigation of hallucinogenic and related beta-carbolines.
Drug and alcohol dependence 1998;50(2):99-107.
1998: Egan C T; Herrick-Davis K; Miller K; Glennon R A; Teitler M
Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
Psychopharmacology 1998;136(4):409-14.
1998: Damaj M I; Fei-Yin M; Dukat M; Glassco W; Glennon R A; Martin B R
Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
The Journal of pharmacology and experimental therapeutics 1998;284(3):1058-65.
1997: Ismaiel A M; Dukat M; Law H; Kamboj R; Fan E; Lee D K; Mazzocco L; Buekschkens D; Teitler M; Pierson M E; Glennon R A
2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
Journal of medicinal chemistry 1997;40(26):4415-9.
1997: Glennon R A; Young R; Dukat M; Cheng Y
Initial characterization of PMMA as a discriminative stimulus.
Pharmacology, biochemistry, and behavior 1997;57(1-2):151-8.
1997: Young R; Glennon R A
Cocaine--stimulus generalization to MDA optical isomers: a reevaluation.
Pharmacology, biochemistry, and behavior 1997;57(1-2):115-8.
1997: Young R; Darmani N A; Elder E L; Dumas D; Glennon R A
Clobenzorex: evidence for amphetamine-like behavioral actions.
Pharmacology, biochemistry, and behavior 1997;56(2):311-6.
1996: Dukat M; Abdel-Rahman A A; Ismaiel A M; Ingher S; Teitler M; Gyermek L; Glennon R A
Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors.
Journal of medicinal chemistry 1996;39(20):4017-26.
1996: Young R; Glennon R A
A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA.
The Journal of pharmacology and experimental therapeutics 1996;276(2):594-601.
1996: Glennon R A; Dukat M; Westkaemper R B; Ismaiel A M; Izzarelli D G; Parker E M
The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
Molecular pharmacology 1996;49(1):198-206.
1996: Glennon R A; Hong S S; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Journal of medicinal chemistry 1996;39(1):314-22.
1995: Glennon R A; Young R; Martin B R; Dal Cason T A
Methcathione ("cat"): an enantiomeric potency comparison.
Pharmacology, biochemistry, and behavior 1995;50(4):601-6.
1995: Ismaiel A M; Arruda K; Teitler M; Glennon R A
Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding.
Journal of medicinal chemistry 1995;38(7):1196-202.
1995: Choudhary M S; Sachs N; Uluer A; Glennon R A; Westkaemper R B; Roth B L
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
Molecular pharmacology 1995;47(3):450-7.
1994: Glennon R A; Hong S S; Dukat M; Teitler M; Davis K
5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist.
Journal of medicinal chemistry 1994;37(18):2828-30.
1994: Glennon R A; Dukat M; el-Bermawy M; Law H; De los Angeles J; Teitler M; King A; Herrick-Davis K
Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines.
Journal of medicinal chemistry 1994;37(13):1929-35.
1994: Glennon R A; Ablordeppey S Y; Ismaiel A M; el-Ashmawy M B; Fischer J B; Howie K B
Structural features important for sigma 1 receptor binding.
Journal of medicinal chemistry 1994;37(8):1214-9.
1994: Westkaemper R B; Glennon R A
Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
NIDA research monograph 1994;146():263-83.
1994: Glennon R A
Classical hallucinogens: an introductory overview.
NIDA research monograph 1994;146():4-32.
1994: Damaj M I; Glennon R A; Martin B R
Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice.
Brain research bulletin 1994;33(2):199-203.
1993: Glennon R A
MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM.
Pharmacology, biochemistry, and behavior 1993;46(2):459-62.
1993: Ismaiel A M; De Los Angeles J; Teitler M; Ingher S; Glennon R A
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
Journal of medicinal chemistry 1993;36(17):2519-25.
1993: Glennon R A; Young R; Herndon J L
Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs.
Pharmacology, biochemistry, and behavior 1993;45(4):865-9.
1993: Young R; Glennon R A
Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex.
Pharmacology, biochemistry, and behavior 1993;45(1):229-31.
1992: Herndon J L; Ismaiel A; Ingher S P; Teitler M; Glennon R A
Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
Journal of medicinal chemistry 1992;35(26):4903-10.
1992: Glennon R A; Higgs R; Young R; Issa H
Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: antagonism by 5-hydroxytryptamine3 antagonists.
Pharmacology, biochemistry, and behavior 1992;43(4):1099-106.
1992: Glennon R A; Higgs R
Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline.
Pharmacology, biochemistry, and behavior 1992;43(3):759-63.
1992: Herndon J L; Pierson M E; Glennon R A
Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
Pharmacology, biochemistry, and behavior 1992;43(3):739-48.
1992: Darmani N A; Martin B R; Glennon R A
Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin.
The Journal of pharmacology and experimental therapeutics 1992;262(2):692-8.
1992: Darmani N A; Martin B R; Glennon R A
Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
Pharmacology, biochemistry, and behavior 1992;41(3):519-27.
1992: Glennon R A; Young R; Dukat M
5-HT3 agonist 2-methylserotonin as a training drug in discrimination studies.
Pharmacology, biochemistry, and behavior 1992;41(2):361-4.
1992: Young R; Glennon R A
Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
European journal of pharmacology 1992;212(1):117-9.
1992: Glennon R A; Raghupathi R; Bartyzel P; Teitler M; Leonhardt S
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
Journal of medicinal chemistry 1992;35(4):734-40.
1992: Glennon R A; Teitler M; Sanders-Bush E
Hallucinogens and serotonergic mechanisms.
NIDA research monograph 1992;119():131-5.
1991: Westkaemper R B; Glennon R A
Approaches to molecular modeling studies and specific application to serotonin ligands and receptors.
Pharmacology, biochemistry, and behavior 1991;40(4):1019-31.
1991: Glennon R A; Dukat M
Serotonin receptors and their ligands: a lack of selective agents.
Pharmacology, biochemistry, and behavior 1991;40(4):1009-17.
1991: Glennon R A; Yousif M Y; Ismaiel A M; el-Ashmawy M B; Herndon J L; Fischer J B; Server A C; Howie K J
Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands.
Journal of medicinal chemistry 1991;34(12):3360-5.
1991: Raghupathi R K; Rydelek-Fitzgerald L; Teitler M; Glennon R A
Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity.
Journal of medicinal chemistry 1991;34(8):2633-8.
1991: Glennon R A; Ismaiel A M; Smith J D; Yousif M; el-Ashmawy M; Herndon J L; Fischer J B; Howie K J; Server A C
Binding of substituted and conformationally restricted derivatives of N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane at sigma-receptors.
Journal of medicinal chemistry 1991;34(6):1855-9.
1991: Glennon R A; Smith J D; Ismaiel A M; el-Ashmawy M; Battaglia G; Fischer J B
Identification and exploitation of the sigma-opiate pharmacophore.
Journal of medicinal chemistry 1991;34(3):1094-8.
1991: Darmani N A; Martin B R; Pandey U; Glennon R A
Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors.
Pharmacology, biochemistry, and behavior 1991;38(2):353-7.
1991: Glennon R A; Darmani N A; Martin B R
Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents.
Life sciences 1991;48(26):2493-8.
1991: Glennon R A
Discriminative stimulus properties of hallucinogens and related designer drugs.
NIDA research monograph 1991;(116):25-44.
1990: Glennon R A; De Vry J; Spencer D G; Glaser T
Stimulus properties of tiflucarbine: a novel antidepressant agent.
Pharmacology, biochemistry, and behavior 1990;37(4):769-71.
1990: Higgs R A; Glennon R A
Stimulus properties of ring-methyl amphetamine analogs.
Pharmacology, biochemistry, and behavior 1990;37(4):835-7.
1990: Rydelek-Fitzgerald L; Teitler M; Fletcher P W; Ismaiel A M; Glennon R A
NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Brain research 1990;532(1-2):191-6.
1990: Appel N M; Mitchell W M; Garlick R K; Glennon R A; Teitler M; De Souza E B
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
The Journal of pharmacology and experimental therapeutics 1990;255(2):843-57.
1990: Glennon R A; Battaglia G; Smith J D
(-)PPAP: a new and selective ligand for sigma binding sites.
Pharmacology, biochemistry, and behavior 1990;37(3):557-9.
1990: Glennon R A; Chaurasia C; Titeler M
Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region.
Journal of medicinal chemistry 1990;33(10):2777-84.
1990: Glennon R A
Do classical hallucinogens act as 5-HT2 agonists or antagonists?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(5-6):509-17.
1990: Yousif M Y; Fitzgerald R L; Narasimhachari N; Rosecrans J A; Blanke R V; Glennon R A
Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats.
Drug and alcohol dependence 1990;26(2):127-35.
1990: Darmani N A; Martin B R; Glennon R A
Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice.
European journal of pharmacology 1990;186(1):115-8.
1990: Darmani N A; Martin B R; Pandey U; Glennon R A
Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions.
Pharmacology, biochemistry, and behavior 1990;37(1):95-9.
1990: Darmani N A; Martin B R; Pandey U; Glennon R A
Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Pharmacology, biochemistry, and behavior 1990;36(4):901-6.
1990: Seggel M R; Yousif M Y; Lyon R A; Titeler M; Roth B L; Suba E A; Glennon R A
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors.
Journal of medicinal chemistry 1990;33(3):1032-6.
1990: Glennon R A; Misenheimer B
Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh").
Pharmacology, biochemistry, and behavior 1990;35(3):517-21.
1990: Ismaiel A M; Titeler M; Miller K J; Smith T S; Glennon R A
5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
Journal of medicinal chemistry 1990;33(2):755-8.
1990: Teitler M; Leonhardt S; Appel N M; De Souza E B; Glennon R A
Receptor pharmacology of MDMA and related hallucinogens.
Annals of the New York Academy of Sciences 1990;600():626-38; discussion 638-9.
1990: Glennon R A
Phenylalkylamine stimulants, hallucinogens, and designer drugs.
NIDA research monograph 1990;105():154-60.
1989: Glennon R A; Ismaiel A E; McCarthy B G; Peroutka S J
Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study.
European journal of pharmacology 1989;168(3):387-92.
1989: Glennon R A; Naiman N A; Pierson M E; Smith J D; Ismaiel A M; Titeler M; Lyon R A
N-(phthalimidoalkyl) derivatives of serotonergic agents: a common interaction at 5-HT1A serotonin binding sites?
Journal of medicinal chemistry 1989;32(8):1921-6.
1989: Glennon R A; Misenheimer B R
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
Pharmacology, biochemistry, and behavior 1989;33(4):909-12.
1989: Fitzgerald R L; Blanke R V; Glennon R A; Yousif M Y; Rosecrans J A; Poklis A
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood.
Journal of chromatography 1989;490(1):59-69.
1989: Pierson M E; Lyon R A; Titeler M; Schulman S B; Kowalski P; Glennon R A
Design and synthesis of propranolol analogues as serotonergic agents.
Journal of medicinal chemistry 1989;32(4):859-63.
1989: Naiman N; Lyon R A; Bullock A E; Rydelek L T; Titeler M; Glennon R A
2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
Journal of medicinal chemistry 1989;32(1):253-6.
1989: Glennon R A
Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships.
NIDA research monograph 1989;94():43-67.
1989: Fitzgerald R L; Blanke R V; Rosecrans J A; Glennon R A
Stereochemistry of the metabolism of MDMA to MDA.
Life sciences 1989;45(4):295-301.
1988: Glennon R A; Naiman N A; Lyon R A; Titeler M
Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands.
Journal of medicinal chemistry 1988;31(10):1968-71.
1988: Glennon R A; Ismaiel A E; Martin B; Poff D; Sutton M
A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine.
Pharmacology, biochemistry, and behavior 1988;31(1):9-13.
1988: Glennon R A; Naiman N A; Pierson M E; Titeler M; Lyon R A; Weisberg E
NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
European journal of pharmacology 1988;154(3):339-41.
1988: Glennon R A; Titeler M; Lyon R A
A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
Pharmacology, biochemistry, and behavior 1988;30(3):597-601.
1988: Glennon R A; Titeler M; Lyon R A; Slusher R M
N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
Journal of medicinal chemistry 1988;31(4):867-70.
1988: Glennon R A; Yousif M; Patrick G
Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
Pharmacology, biochemistry, and behavior 1988;29(3):443-9.
1988: Lyon R A; Titeler M; Seggel M R; Glennon R A
Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.
European journal of pharmacology 1988;145(3):291-7.
1988: Glennon R A; Seggel M R; Soine W H; Herrick-Davis K; Lyon R A; Titeler M
[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors.
Journal of medicinal chemistry 1988;31(1):5-7.
1988: Glennon R A; Pierson M E; McKenney J D
Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine.
Pharmacology, biochemistry, and behavior 1988;29(1):197-9.
1988: Titeler M; Lyon R A; Glennon R A
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Psychopharmacology 1988;94(2):213-6.
1987: Titeler M; Lyon R A; Davis K H; Glennon R A
Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Biochemical pharmacology 1987;36(19):3265-71.
1987: Rosecrans J A; Glennon R A
The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice.
Pharmacology, biochemistry, and behavior 1987;28(1):39-42.
1987: Glennon R A; Titeler M; Seggel M R; Lyon R A
N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
Journal of medicinal chemistry 1987;30(5):930-2.
1987: Glennon R A; Little P J; Rosecrans J A; Yousif M
The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice.
Pharmacology, biochemistry, and behavior 1987;26(2):425-6.
1987: Young R; Glennon R A
Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR).
Psychopharmacology 1987;93(4):529-33.
1987: Young R; Glennon R A; Dewey W L
Effects of pyrazolopyridines and a triazolopyridazine on the pentobarbital discriminative stimulus.
Psychopharmacology 1987;93(4):494-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Richard Glennon

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Richard Glennon (preview)

All Publications